The weekly litigation news digest is live. Subscribe now

IP Verse

Biomadison competitive analysis

Loading summary...

Latest patents of Biomadison opposed by its competitors

Explore Biomadison's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3030905
Apr 3, 2024Botulinum Toxin Assay With Improved Sensitivity1
EP3270162
Aug 16, 2023Botulinum Toxin Assay With Improved Sensitivity1
EP2800973
May 16, 2018Methods And Compounds For Increasing Sensitivity Of Botulinum Assays1

Latest PTAB cases involving Biomadison

Discover the latest PTAB cases involving Biomadison, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biomadison with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOMADISON - 3 - -
MERZ PHARMA176 - -